These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24728612)

  • 1. Framework for the analysis of nanotechnologies' impacts and ethical acceptability: basis of an interdisciplinary approach to assessing novel technologies.
    Patenaude J; Legault GA; Beauvais J; Bernier L; Béland JP; Boissy P; Chenel V; Daniel CÉ; Genest J; Poirier MS; Tapin D
    Sci Eng Ethics; 2015 Apr; 21(2):293-315. PubMed ID: 24728612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology and patents - how can potential risks be assessed?
    Senjen R
    Recent Pat Food Nutr Agric; 2012 Dec; 4(3):245-9. PubMed ID: 23061648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems theory and the ethics of human enhancement: a framework for NBIC convergence.
    Khushf G
    Ann N Y Acad Sci; 2004 May; 1013():124-49. PubMed ID: 15194611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Science, ethics, and the "problems" of governing nanotechnologies.
    Hogle LF
    J Law Med Ethics; 2009; 37(4):749-58. PubMed ID: 20122114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.
    Kuzma J; Najmaie P; Larson J
    J Law Med Ethics; 2009; 37(4):546-86. PubMed ID: 20122100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using expert elicitation to prioritize resource allocation for risk identification for nanosilver.
    Fauss E; Gorman ME; Swami N
    J Law Med Ethics; 2009; 37(4):770-80. PubMed ID: 20122116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical and scientific issues of nanotechnology in the workplace.
    Schulte PA; Salamanca-Buentello F
    Environ Health Perspect; 2007 Jan; 115(1):5-12. PubMed ID: 17366812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of disciplinary cultures of researchers and research trainees on the acceptability of nanocarriers for drug delivery in different contexts of use: a mixed-methods study.
    Chenel V; Boissy P; Cloarec JP; Patenaude J
    J Nanopart Res; 2015; 17(4):186. PubMed ID: 25960687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Strength of Ethical Matrixes as a Tool for Normative Analysis Related to Technological Choices: The Case of Geological Disposal for Radioactive Waste.
    Kermisch C; Depaus C
    Sci Eng Ethics; 2018 Feb; 24(1):29-48. PubMed ID: 28281155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Just a Cog in the Machine? The Individual Responsibility of Researchers in Nanotechnology is a Duty to Collectivize.
    Spruit SL; Hoople GD; Rolfe DA
    Sci Eng Ethics; 2016 Jun; 22(3):871-87. PubMed ID: 26538353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical analysis to improve decision-making on health technologies.
    Saarni SI; Hofmann B; Lampe K; Lühmann D; Mäkelä M; Velasco-Garrido M; Autti-Rämö I
    Bull World Health Organ; 2008 Aug; 86(8):617-23. PubMed ID: 18797620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will nanotechnology make the world a better place?
    Parr D
    Trends Biotechnol; 2005 Aug; 23(8):395-8. PubMed ID: 15967522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A matter of accuracy. Nanobiochips in diagnostics and in research: ethical issues as value trade-offs.
    Le Roux R
    Sci Eng Ethics; 2015 Apr; 21(2):343-58. PubMed ID: 24793012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Just War Theory and the ethical governance of research.
    Malsch I
    Sci Eng Ethics; 2013 Jun; 19(2):461-86. PubMed ID: 22371034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the Gap between Social Acceptance and Ethical Acceptability.
    Taebi B
    Risk Anal; 2017 Oct; 37(10):1817-1827. PubMed ID: 27862106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organisms.
    Nelson KC; Andow DA; Banker MJ
    J Law Med Ethics; 2009; 37(4):732-48. PubMed ID: 20122113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioethics and law: a developmental perspective.
    van der Burg W
    Bioethics; 1997 Apr; 11(2):91-114. PubMed ID: 11654795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.